Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Repurchased
Ratios

Anaptysbio (ANAB) Long-Term Debt Repayments (2018 - 2020)

Historic Long-Term Debt Repayments for Anaptysbio (ANAB) over the last 3 years, with Q1 2020 value amounting to $1.4 million.

  • Anaptysbio's Long-Term Debt Repayments fell 2666.67% to $1.4 million in Q1 2020 from the same period last year, while for Dec 2020 it was $1.4 million, marking a year-over-year decrease of 8166.67%. This contributed to the annual value of $1.4 million for FY2020, which is 8166.67% down from last year.
  • Per Anaptysbio's latest filing, its Long-Term Debt Repayments stood at $1.4 million for Q1 2020, which was down 2666.67% from $1.9 million recorded in Q4 2019.
  • Anaptysbio's 5-year Long-Term Debt Repayments high stood at $1.9 million for Q2 2018, and its period low was $1.2 million during Q1 2018.
  • Over the past 3 years, Anaptysbio's median Long-Term Debt Repayments value was $1.9 million (recorded in 2018), while the average stood at $1.8 million.
  • In the last 5 years, Anaptysbio's Long-Term Debt Repayments skyrocketed by 5000.0% in 2019 and then tumbled by 2666.67% in 2020.
  • Over the past 3 years, Anaptysbio's Long-Term Debt Repayments (Quarter) stood at $1.9 million in 2018, then changed by 0.0% to $1.9 million in 2019, then decreased by 26.67% to $1.4 million in 2020.
  • Its Long-Term Debt Repayments was $1.4 million in Q1 2020, compared to $1.9 million in Q4 2019 and $1.9 million in Q3 2019.